Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

liraglutide

Study shows Sanofi’s Zaltrap effective in colorectal cancer

Reinforces prospects following US approval

- PMLiVE

Sanofi acquires Colombian pharma manufacturing firm Genfar

Expands its Latin American generics portfolio

- PMLiVE

Sanofi promotes diabetes expert Paul Chew to chief medical officer

Takes over from Jean-Pierre Lehner who retires

- PMLiVE

Novo drops late-stage haemophilia candidate vatreptacog alfa

Patients developed anti-drug antibodies during phase III clinical trial

- PMLiVE

Sanofi plans 900 job cuts in France in upheaval of research

Future of Toulouse site remains in balance

Novo Nordisk invests $100m in research in China

Expands existing site in Beijing

- PMLiVE

Sanofi signs tuberculosis research deal with TB Alliance

Aims to shorten regimens and tackle drug-resistant forms of infection

- PMLiVE

J&J to launch ‘innovation centres’ in US, UK and China

Will target local life sciences partnerships in early-stage innovation

- PMLiVE

Sanofi to announce up to 2,500 job cuts next week says paper

Le Figaro claims losses will mainly affect France

- PMLiVE

Sanofi taps Oncodesign for kinase inhibitor platform

French firms form €130m alliance

- PMLiVE

FDA clears Sanofi’s oral MS drug Aubagio

Will compete with Novartis’ Gilenya

- PMLiVE

Sanofi’s dengue vaccine shows signs of efficacy

Pharma company shows off encouraging phase IIb data, but some questions remain

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links